{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:36:02Z","timestamp":1782578162996,"version":"3.54.5"},"reference-count":44,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9547","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T11:26:48Z","timestamp":1538566008000},"source":"Crossref","is-referenced-by-count":7,"title":["Identification of a role for serum aldo\u2011keto reductase family 1 member B10 in early detection of hepatocellular carcinoma"],"prefix":"10.3892","author":[{"given":"Chao","family":"Han","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanzhu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"key20200714084653_b1-ol-0-0-9547","first-page":"1141","article-title":"Ministry of Health of the People's Republic of China: Diagnosis, management, and treatment of hepatocellular carcinoma (V2011)","volume":"11","year":"2011","journal-title":"J Clini Hepatol"},{"key":"key20200714084653_b2-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"key20200714084653_b3-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"key20200714084653_b4-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin Liver Dis"},{"key":"key20200714084653_b5-ol-0-0-9547","first-page":"89","article-title":"The impact of anti-HBV treatment on the occurrence and recurrence of hepatocellular carcinoma: Focus on Asian studies","volume":"19","author":"Yang","year":"2015","journal-title":"Discov Med"},{"key":"key20200714084653_b6-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"key20200714084653_b7-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"key20200714084653_b8-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","article-title":"Biomarkers for the early diagnosis of hepatocellular carcinoma","volume":"21","author":"Tsuchiya","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200714084653_b9-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/s-2006-951606","article-title":"Serum markers of hepatocellular carcinoma","volume":"26","author":"Spangenberg","year":"2006","journal-title":"Semin Liver Dis"},{"key":"key20200714084653_b10-ol-0-0-9547","article-title":"Alpha-foetoprotein and\/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"CD002799","author":"Aghoram","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200714084653_b11-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"882","DOI":"10.5604\/16652681.1171776","article-title":"Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas","volume":"14","author":"Chun","year":"2015","journal-title":"Ann Hepatol"},{"key":"key20200714084653_b12-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.25814","article-title":"Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis","volume":"56","author":"Giannini","year":"2012","journal-title":"Hepatology"},{"key":"key20200714084653_b13-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"e0140067","DOI":"10.1371\/journal.pone.0140067","article-title":"Diagnostic value of the combination of Golgi Protein 73 and alpha-fetoprotein in hepatocellular carcinoma: A meta-analysis","volume":"10","author":"Dai","year":"2015","journal-title":"PLoS One"},{"key":"key20200714084653_b14-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0009-8981(01)00644-1","article-title":"AFP-L3: A new generation of tumor marker for hepatocellular carcinoma","volume":"313","author":"Li","year":"2001","journal-title":"Clin Chim Acta"},{"key":"key20200714084653_b15-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N Engl J Med"},{"key":"key20200714084653_b16-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"key20200714084653_b17-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cgh.2008.08.041","article-title":"Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma","volume":"7","author":"Sterling","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20200714084653_b18-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"key":"key20200714084653_b19-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000346080","article-title":"A combination of \u03b1-fetoprotein and des-U-carboxy prothrombin is superior in detection of hepatocellular carcinoma","volume":"87","author":"Ertle","year":"2013","journal-title":"Digestion"},{"key":"key20200714084653_b20-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","article-title":"Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion","volume":"62","author":"Pote","year":"2015","journal-title":"J Hepatol"},{"key":"key20200714084653_b21-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1074\/jbc.M707650200","article-title":"Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells","volume":"283","author":"Ma","year":"2008","journal-title":"J Biol Chem"},{"key":"key20200714084653_b22-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"26742","DOI":"10.1074\/jbc.M109.022897","article-title":"Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"key20200714084653_b23-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1074\/jbc.273.19.11429","article-title":"Identification and characterization of a novel human aldose reductase-like gene","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"key20200714084653_b24-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1039\/B612702A","article-title":"Aldehyde metabolism in the cardiovascular system","volume":"3","author":"Conklin","year":"2007","journal-title":"Mol Biosyst"},{"key":"key20200714084653_b25-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20061743","article-title":"Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes","volume":"405","author":"Spite","year":"2007","journal-title":"Biochem J"},{"key":"key20200714084653_b26-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/ijc.22933","article-title":"Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention","volume":"121","author":"Yan","year":"2007","journal-title":"Int J Cancer"},{"key":"key20200714084653_b27-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cbi.2008.10.021","article-title":"Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes","volume":"178","author":"Martin","year":"2009","journal-title":"Chem Biol Interact"},{"key":"key20200714084653_b28-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrc.2009.06.123","article-title":"Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels","volume":"387","author":"Zhong","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200714084653_b29-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1042\/bj20021818","article-title":"Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: Consequences for retinoid metabolism","volume":"373","author":"Crosas","year":"2003","journal-title":"Biochem J"},{"key":"key20200714084653_b30-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/BJ20051988","article-title":"Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases\/reductases and aldo-keto reductases with retinoids","volume":"399","author":"Gallego","year":"2006","journal-title":"Biochem J"},{"key":"key20200714084653_b31-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.humpath.2013.12.002","article-title":"Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions","volume":"45","author":"Matkowskyj","year":"2014","journal-title":"Hum Pathol"},{"key":"key20200714084653_b32-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhep.2009.11.005","article-title":"Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours","volume":"52","author":"Heringlake","year":"2010","journal-title":"J Hepatol"},{"key":"key20200714084653_b33-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BJ20110111","article-title":"Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway","volume":"438","author":"Luo","year":"2011","journal-title":"Biochem J"},{"key":"key20200714084653_b34-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/j.1478-3231.2012.02827.x","article-title":"Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: Association with serum alpha-fetoprotein and hepatocellular carcinoma","volume":"32","author":"Sato","year":"2012","journal-title":"Liver Int"},{"key":"key20200714084653_b35-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.1111\/hepr.12725","article-title":"Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk","volume":"47","author":"Mori","year":"2017","journal-title":"Hepatol Res"},{"key":"key20200714084653_b36-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3748\/wjg.v22.i33.7569","article-title":"Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication","volume":"22","author":"Murata","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20200714084653_b37-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1478-3231.2011.02511.x","article-title":"AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: A clinicopathological study of 168 cases","volume":"31","author":"Schmitz","year":"2011","journal-title":"Liver Int"},{"key":"key20200714084653_b38-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"648","DOI":"10.5009\/gnl13406","article-title":"High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma","volume":"8","author":"Ha","year":"2014","journal-title":"Gut Liver"},{"key":"key20200714084653_b39-ol-0-0-9547","first-page":"13","article-title":"Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association: The guideline of prevention and treatment for chronic hepatitis B (2010 version)","volume":"19","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20200714084653_b40-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: The BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"key20200714084653_b41-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"key20200714084653_b42-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J Hepatol"},{"key":"key20200714084653_b43-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.3748\/wjg.v21.i42.12003","article-title":"Diagnostic and therapeutic management of hepatocellular carcinoma","volume":"21","author":"Bellissimo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200714084653_b44-ol-0-0-9547","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/lt.24117","article-title":"Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation","volume":"21","author":"Chaiteerakij","year":"2015","journal-title":"Liver Transpl"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:43:58Z","timestamp":1594719838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9547","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]}}}